Chinese multiple dose escalation (MDE) high dose study

Trial Identifier: D5671C00005
Sponsor: AstraZeneca
NCTID:: NCT05437848
Start Date: February 2022
Primary Completion Date: December 2022
Study Completion Date: December 2022
Condition: Endocrine - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
Simplified Chinese (China)

Trial Locations